Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Analogue-to-digital converter
Methods and devices for coding and decoding images, computer program implementing them and information carrier enabling their implementation
Capacitance sensing
Systems and methods for generating a hybrid text string from two or more text strings generated by multiple automated speech recognition systems
Security authentication method, apparatus, and system
Optical fixing device and image forming apparatus
Perception-based artifact quantification for volume rendering
  Randomly Featured Patents
Process for the manufacture of power-MOS semiconductor devices
Multilayer packaging film
Watering can
Process for removing aluminum phenoxide catalyst from phenol alkylation products
Conditioned sheets for binding and method/apparatus for making same
End-of-travel device for actuating systems of roller blinds or sun shades
Cursor control method and apparatus
Oligodeoxynucleotide and its use to induce an immune response
Process for preparing 4-trifluoromethylsulfinylpyrazole derivative
Method and apparatus for computing capacity of a region for non-Manhattan routing